IVS PlatformTM

When beneficial microbes are ingested and reach the gut, they find themselves in a highly competitive environment, dominated by a large and diverse community. In fact, probiotics are typically outnumbered by a ratio of a million to one. This makes it extremely difficult for these probiotics to survive, establish themselves, and offer health benefits. Most commercial strains were developed without accounting for these ecological challenges. 

Synbiotic Health’s In Vivo Selection or IVS Platform addresses this issue by imposing selective conditions in vivo, or ‘inside the body,’ that favor the most competitive, robust, and persistent strains.

Their published research, both in preclinical and clinical settings, shows that IVS-selected microbes have clear advantages, including higher abundance, better persistence in the gut, and more significant health benefits compared to traditional probiotic strains.